News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Karthik Chidambaram, Pharmaceutical Management Science Assn.

Advertisement

Articles by Karthik Chidambaram, Pharmaceutical Management Science Assn.

For better patient data in pharma, think CUPID

ByKarthik Chidambaram, Pharmaceutical Management Science Assn.
November 9th 2015

A Common Universal Patient de-IDentifier could greatly enhance the value of industry data assets

Advertisement

Latest Updated Articles

  • For better patient data in pharma, think CUPID
    For better patient data in pharma, think CUPID

    Published: November 9th 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions

2

AI Is Redefining Pharma Forecasting, and Eliminating the Old Speed-Versus-Compliance Trade-Off

3

WeightWatchers to Offer Novo Nordisk’s Oral Wegovy, if Approved Next Year

4

Pharma Pulse: FDA Advances New Approval Pathway, as Obesity Care and Metabolic Treatments Gain Momentum

5

Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us